Literature DB >> 21481576

Clonality and phenotyping analysis of alveolar lymphocytes is suggestive of pulmonary MALT lymphoma.

Raphael Borie1, Marie Wislez, Martine Antoine, Jocelyne Fleury-Feith, Gabriel Thabut, Bruno Crestani, Isabelle Monnet, Hilario Nunes, Marie-Helene Delfau-Larue, Jacques Cadranel.   

Abstract

BACKGROUND: Mucosa-associated lymphoid tissue (MALT) lymphoma, a low-grade B-cell extranodal lymphoma, is the most frequent subset of primary pulmonary lymphoma (PPL). It often associates with connective tissue disease (CTD). We aimed to evaluate the impact of concomitant CTD on diagnostic value of flow cytometry and genetic clonality analyses for the diagnostic of MALT lymphoma.
METHODS: All chest disease and pathology departments of teaching hospitals in Paris were contacted to identify patients with a histological diagnosis of PPL of the MALT subtype with or without associated CTD. We identified 44 patients in the lymphoma group; 11 had a CTD and were matched to 11 patients with CTD but without lymphoma.
RESULTS: Results of BAL analyses of MALT-PPL showed normal cellularity (370 cells/mm(3) [range 21-2300]) but increased proportion of lymphocytes (31.5% [80-2]) of the B-cell subtype (20% [1-88]). A B-cell clone was detected in 82% of cases, and specificity of clonality was 90%. Interestingly, BAL analysis results different by presence or not of a CTD. The frequency of B lymphocyte alveolitis was significantly greater in MALT patients without than with CTD (34% vs 6.5%, p = 0.007). However, BAL results for patients with CTD did not differ between those with and without lymphoma.
CONCLUSION: BAL results may be highly suggestive of pulmonary MALT lymphoma. The proportion of B-cells may vary depending on the presence of an associated CTD, but clonality analyses remained informative for the diagnostic of MALT lymphoma.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21481576     DOI: 10.1016/j.rmed.2011.03.018

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  5 in total

1.  Diagnostic and prognostic factors for patients with primary pulmonary non-Hodgkin's lymphoma: A 16-year single-center retrospective study.

Authors:  Jiang Qian; Dong-Lan Luo; Jin-E Zhang; Wen-Yu Li; Xing-Lin Gao; Xiang-Feng Fang; Hong An; Jun-Liang Deng; Qiong Li; Jian Wu
Journal:  Oncol Lett       Date:  2019-06-12       Impact factor: 2.967

Review 2.  Role of Helicobacter pylori in gastric mucosa-associated lymphoid tissue lymphomas.

Authors:  Marta-Isabel Pereira; José Augusto Medeiros
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

3.  Primary pulmonary mucosa-associated lymphoid tissue lymphoma: A case report.

Authors:  Mohammad Reza Hosseini Siyanaki; Elham Askari; Sara Haseli; Nazanin Sadraei
Journal:  Radiol Case Rep       Date:  2022-10-08

Review 4.  Primary pulmonary lymphoproliferative neoplasms.

Authors:  Victoria K Tang; Praveen Vijhani; Sujith V Cherian; Manju Ambelil; Rosa M Estrada-Y-Martin
Journal:  Lung India       Date:  2018 May-Jun

5.  Combined detection of lymphocyte clonality and MALT1 translocations in bronchoalveolar lavage fluid for diagnosing pulmonary lymphomas.

Authors:  Takashi Kido; Hiroshi Ishimoto; Hiroshi Ishii; Kanako Hara; Mutsumi Ozasa; Hiroki Kawabata; Toshinori Kawanami; Yu Suzuki; Hiroki Yoshikawa; Atsuko Hara; Noriho Sakamoto; Nobuhiro Matsumoto; Chiharu Yoshii; Junya Fukuoka; Masaki Fujita; Masamitsu Nakazato; Junichi Kadota; Hiroshi Mukae; Kazuhiro Yatera
Journal:  Sci Rep       Date:  2021-12-06       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.